单位：[1]Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC[2]Department of Pharmacy, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing, China[3]Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China[4]Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China医技科室药学部首都医科大学附属北京友谊医院[5]Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China[6]Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC
School of Pharmaceutical Sciences, Peking University [69003Y0052]; Novo NordiskNovo Nordisk; Sanofi; vTv Therapeutics; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1-TR-002489]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG-056479, R01-CA-174453, R01-HL-118255, R21-HD-080214]; Biostatistics, Epidemiology, and Research Design (BERD), North Carolina Translational and Clinical Sciences Institute [UL1-TR-002489]; AmgenAmgen; AstraZenecaAstraZeneca; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA174453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL118255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK007634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056479] Funding Source: NIH RePORTER
第一作者单位：[1]Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Wang Tiansheng,Lu Wenchao,Li Dandan,et al.Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting[J].DIABETES CARE.2019,42(6):E89-E91.doi:10.2337/dc18-1609.
APA：
Wang, Tiansheng,Lu, Wenchao,Li, Dandan,Tang, Huilin,Yang, Jeff Y....&Sturmer, Til.(2019).Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting.DIABETES CARE,42,(6)
MLA：
Wang, Tiansheng,et al."Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting".DIABETES CARE 42..6(2019):E89-E91
医学